capital raising, page-39

Ss sanofi have paid us 50m and have exclusive rights to about 3 of the 10 available classes of drugs that could be delivered with our device.

I believe they will seek an access payment to the technology from any other pharma that wants to use the device. Short term cash flow here.

I also believe they will do another deal to industrialize the select device hopefully with sanofi to bring that one into production sooner than later.

Long term with this kind of backing next year and a factory they own they will be unstoppable !!!!!!